SEC Form 4 · accession 0001225208-16-042699
BOSTON SCIENTIFIC CORP · BSX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Timothy A. Pratt
Officer — EVP, GC & Chief Admin Officer
Period of report
Dec 1, 2016
Accepted (ET)
Dec 5, 2016 · 4:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885725
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 1, 2016 | M | 18,761 | $13.56 | A | 260,430 | D | |
| Common StockF2 | Dec 1, 2016 | S | 26,726 | $20.4807 | D | 233,704 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | $13.56 | Dec 1, 2016 | M | 18,761 | D | — | May 1, 2018 | Common Stock | 18,761 | 0 | D |
Explanation of responses
- F1The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.
- F2Represents the weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $20.422 to $20.515, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- F3Grant to the reporting person of an option to purchase a specified number of shares of common stock on May 1, 2009, the first anniversary of the date of grant.